BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:08 PM
 | 
Jan 11, 2010
 |  BC Extra  |  Company News

FDA says second Levadex trial unnecessary

Map Pharmaceuticals Inc. (NASDAQ:MAPP) jumped $3.16 (33%) to $12.75 on Monday after FDA said that a second pivotal efficacy trial for...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >